淋巴结状态参与宫颈癌分期合理性的研究进展  

Research progress on rationality of lymph node status involved in cervical cancer staging system

作　　者：常虹 吴玉梅[1] CHANG Hong;WU Yumei(Department of Gynecology Oncology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100006,China)

机构地区：[1]首都医科大学附属北京妇产医院妇瘤科,北京100006

出　　处：《中国医药导报》2022年第22期54-57,共4页China Medical Herald

基　　金：北京市科学技术委员会重点项目(Z191100006619035)。

摘　　要：宫颈癌是最常见的女性生殖系统恶性肿瘤,既往采用临床分期,2018年国际妇产科联盟首次提出将影像学及病理学诊断的淋巴结转移设立为ⅢC期,体现了淋巴结阳性是影响宫颈癌患者预后的独立危险因素。与此同时,淋巴结转移个数、局部肿瘤大小及宫旁浸润程度也是影响预后的重要决定因素。影像学可通过彩色多普勒超声、CT、MRI、PET/CT等诊断淋巴结转移。经行淋巴结切除术或联合腹主动脉旁淋巴结切除术,局部晚期患者亦可行腹膜后淋巴结切除术后行病理学诊断淋巴结转移。被证实存在淋巴结转移患者的治疗方式建议首选同步放化疗。本文对淋巴结状态参与宫颈癌分期合理性的相关研究作一综述。Cervical cancer is the most common malignant tumor of the female reproductive system.In the past,clinical staging was used,in 2018,the International Federation of Obstetrics and Gynecology first proposed to set the lymph node metastasis diagnosed by imaging and pathology as stageⅢC,reflecting that lymph node positivity was independent risk factors for prognosis of patients with cervical cancer.At the same time,the number of lymph node metastases,the size of the local tumor and the degree of parametrial invasion are also important determinants of prognosis.Imaging can diagnose lymph node metastasis by color doppler ultrasound,CT,MRI,PET/CT,etc.After lymphadenectomy whether or not combine abdominal aortic lymphadenectomy,patients with locally advanced disease can also undergo pathological diagnosis of lymph node metastasis after retroperitoneal lymphadenectomy.Concurrent chemoradiotherapy is recommended for the treatment of patients with confirmed lymph node metastasis.This article reviews the studies on the involvement of lymph node status in the staging of cervical cancer.

关 键 词：宫颈肿瘤 国际妇产科联盟 分期系统 淋巴结转移 

分 类 号：R736.1[医药卫生—肿瘤]